
Vorasidenib analyses featured at SNO 2026 examine longer-term outcomes and seizure burden in IDH-mutant glioma, underscoring the importance of sustained monitoring during oral therapy.
Pharmacy Practice in Focus: Oncology
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Oncology-trained nurses who perform chart reviews and reassessments prior to refills being shipped out to patients help reduce the number of unnecessary fills.






